FDAs injectable-route concern highlights limited human safety data, aggregation risk, and peptide-related impurity concerns [8]
Once-weekly semaglutide for weight management: a clinical review
pain reduction radical scavenger and antioxidant actions gastric mucosa healing stomach cell protection against noxious agents improving the healing of intestinal tissues increased vessel recruitment following injury induction improving short-bowel syndrome Unofficially, the peptide has also been claimed to help burn fat, increase muscle, heal the heart, lower blood pressure, help with erectile dysfunction, and increase HGH levels, but there is no data to suggest that, even from lab studies
To be clear, no study has definitively shown that BPC-157 causes cancer in humans
A batch-specific Certificate of Analysis covering all three should be available from any reputable supplier